This article from Sheppard, Mullin, Richter & Hampton LLP is most popular:
- within Food, Drugs, Healthcare and Life Sciences topic(s)
Sheppard, Mullin, Richter & Hampton LLP are most popular:
- within Cannabis & Hemp topic(s)
Healthcare transactions demand more than strong financials. They require a strategy that aligns with investor priorities and industry trends. In this webinar, our advisors will share practical steps for preparing your business, navigating due diligence, and understanding how today's revenue models and regulations impact valuation.
You will walk away with:
- Practical steps to get your organization ready for an M&A or capital raise
- Insights into current value-based care market dynamics
- Understanding of key payor and regulatory trends that may affect deal outcomes
Healthcare executives, founders, and investors exploring growth, M&A, or capital raise opportunities are highly encouraged to attend.
The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.
